Centrale d'achat FHL: fourniture d’anticorps monoclonaux.
Buyer: Fédération des Hôpitaux Luxembourgeois
- Published
- 26 January 2026
- Place of performance
- LU000
- Procedure
- open
- Lots
- 7
- Notice number
- 00054005-2026
- Reference
- e2b74440-58f7-4e2a-ba94-59b87d00eb91
- Official source
- Official source
CPV codes
- 33690000Medicamentos diversos
Description
Fourniture d’anticorps monoclonaux (nivolumab, ipilimumab, pembrolizumab, atezolizumab, durvalumab et avelumab) à 4 établissements membres de la Fédération des Hôpitaux Luxembourgeois: Centre Hospitalier Émile Mayrisch (CHEM), Centre Hospitalier de Luxembourg (CHL), Centre Hospitalier du Nord (CHdN) et Hôpitaux Robert Schuman (HRS).
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Abacus Medicine A/S | €29,824,830 | — |
| Bristol Myers Squibb S.A. | €27,587,410 | — |
| Abacus Medicine A/S | €13,702,000 | — |
| Roche S.A. | €12,154,190 | — |
| Abacus Medicine A/S | €1 | — |
| AstraZeneca Luxembourg S.A. | €1 | — |
| Abacus Medicine A/S | €1 | — |
| Bristol Myers Squibb S.A. | €1 | — |
| Merck S.A. | €1 | — |
| MSD Belgium BV | €1 | — |
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Fédération des Hôpitaux Luxembourgeois (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.